Clinical Trials Browser

Has results × nirogacestat × Plasma cell × Clear all

NCT05090566 2026-02-23

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Phase 2 Active not recruiting

46 enrolled 15 charts

Multiple Myeloma